These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 8301136
1. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. Haak-Frendscho M, Marsters SA, Mordenti J, Brady S, Gillett NA, Chen SA, Ashkenazi A. J Immunol; 1994 Feb 01; 152(3):1347-53. PubMed ID: 8301136 [Abstract] [Full Text] [Related]
4. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Baker D, Butler D, Scallon BJ, O'Neill JK, Turk JL, Feldmann M. Eur J Immunol; 1994 Sep 01; 24(9):2040-8. PubMed ID: 8088324 [Abstract] [Full Text] [Related]
6. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors. Eason JD, Wee S, Kawai T, Hong HZ, Powelson JA, Widmer MB, Cosimi AB. Transplantation; 1995 Jan 27; 59(2):300-5. PubMed ID: 7839455 [Abstract] [Full Text] [Related]
7. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. Plessner HL, Lin PL, Kohno T, Louie JS, Kirschner D, Chan J, Flynn JL. J Infect Dis; 2007 Jun 01; 195(11):1643-50. PubMed ID: 17471434 [Abstract] [Full Text] [Related]
8. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT. J Immunol; 1998 Apr 15; 160(8):4098-103. PubMed ID: 9558121 [Abstract] [Full Text] [Related]
9. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH. Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10535-9. PubMed ID: 1660140 [Abstract] [Full Text] [Related]
10. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein. Lee JH, Cho JH, Yeo J, Lee SH, Yang SH, Sung YC, Kang JH, Park CS. Biologicals; 2013 Mar 01; 41(2):77-83. PubMed ID: 23190454 [Abstract] [Full Text] [Related]
11. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins. Scallon BJ, Trinh H, Nedelman M, Brennan FM, Feldmann M, Ghrayeb J. Cytokine; 1995 Nov 01; 7(8):759-70. PubMed ID: 8664442 [Abstract] [Full Text] [Related]
13. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. Börset M, Medvedev AE, Sundan A, Espevik T. Cytokine; 1996 Jun 01; 8(6):430-8. PubMed ID: 8818539 [Abstract] [Full Text] [Related]
14. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency. Scallon B, Cai A, Radewonuk J, Naso M. Mol Immunol; 2004 May 01; 41(1):73-80. PubMed ID: 15140577 [Abstract] [Full Text] [Related]
18. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody. Corti A, Bagnasco L, Cassani G. Lymphokine Cytokine Res; 1994 Jun 01; 13(3):183-90. PubMed ID: 7524695 [Abstract] [Full Text] [Related]
19. A novel human scFv fragment against TNF-alpha from de novo design method. Chang H, Qin W, Li Y, Zhang J, Lin Z, Lv M, Sun Y, Feng J, Shen B. Mol Immunol; 2007 Jul 01; 44(15):3789-96. PubMed ID: 17485112 [Abstract] [Full Text] [Related]
20. [Characterization of neutralizing activity of murine monoclonal antibodies for construction of anti-human TNF chimeric antibody]. Zhu CS, Ouyang WM, Liu XS, Cao YX, Zhao N, Jin BQ. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov 01; 19(6):576-9. PubMed ID: 15182654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]